Laura Stoppel

Partner at RA Capital Management

Speaker

Laura Stoppel is a Partner on the Investment Team at RA Capital Management. Laura works on both public and private investments and serves as a Board Director for Artiva Biotherapeutics, Nimbus Therapeutics, and Acumen Pharmaceuticals. Previously, Laura covered hematologic malignancies, cell therapies, retinal diseases, and orphan neurodevelopmental disorders. Her graduate research investigated synaptic translation in syndromic autism. Laura holds a BA in Biology and Psychology from Harvard University and a PhD in Neuroscience from MIT.